Cronos Group (NASDAQ:CRON – Get Free Report) is scheduled to announce its earnings results before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Cronos Group (NASDAQ:CRON – Get Free Report) last issued its earnings results on Thursday, February 29th. The company reported ($0.05) earnings per share (EPS) for the quarter. Cronos Group had a negative net margin of 84.15% and a negative return on equity of 3.99%. The firm had revenue of $23.92 million during the quarter, compared to the consensus estimate of $25.15 million. On average, analysts expect Cronos Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Cronos Group Stock Performance
Shares of NASDAQ:CRON opened at $2.64 on Wednesday. Cronos Group has a 52-week low of $1.64 and a 52-week high of $2.99. The company has a market capitalization of $1.01 billion, a P/E ratio of -13.89 and a beta of 1.11. The company has a 50-day simple moving average of $2.42 and a 200 day simple moving average of $2.17.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on CRON
About Cronos Group
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Stories
- Five stocks we like better than Cronos Group
- Why Invest in 5G? How to Invest in 5G Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- How to Invest in Insurance Companies: A Guide
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Industrial Products Stocks Investing
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.